Columbia Financial CLBK
11.33
0.07
0.62%
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 45.3×
Follow CLBK
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
31.84 | 30.46 | 100.15 | 242.65 |
+8 more quarters Free account |
P/S ratio |
3.46 | 3.11 | 3.27 | 3.20 | |
P/FCF ratio |
27.58 | 27.00 | 23.41 | 251.54 | |
P/Operating CF |
564.59 | 64.86 | 49.45 | 101.14 | |
P/B ratio |
1.51 | 1.36 | 1.34 | 1.32 | |
Price to Tangible BV |
1.68 | 1.52 | 1.50 | 1.48 | |
EV/Sales |
5.34 | 4.77 | 5.44 | 5.42 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
37.47 | 35.44 | 34.85 | 183.25 | |
EV/FCF |
42.61 | 41.39 | 38.85 | 425.55 | |
Quick Ratio |
0.03 | 0.04 | 0.03 | 0.03 | |
Current Ratio |
1.00 | 1.00 | 1.01 | 1.01 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
11.29% | 10.74% | 11.64% | 11.85% | |
Debt/Equity |
1.06 | 1.02 | 1.11 | 1.14 | |
Asset Turnover |
0.05 | 0.05 | 0.04 | 0.04 | |
Operating CF/Net income |
0.24 | 1.55 | 2.08 | 1.19 | |
Capex/Depreciation |
(0.42) | (0.88) | (0.26) | (0.40) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
37.11% | 37.50% | 36.41% | 37.40% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.82% | 0.88% | 0.87% | 1.05% | |
Graham Net Nets |
(0.75) | (0.79) | (0.79) | (0.82) | |
Graham Number |
5.44 | 5.20 | 2.79 | 1.75 | |
Earnings Yield |
3.14% | 3.28% | 1.00% | 0.41% | |
Free Cash Flow Yield |
3.63% | 3.70% | 4.27% | 0.40% | |
Revenue per Share |
0.56 | 0.58 | 0.58 | 0.56 | |
Operating CF per Share |
0.01 | 0.11 | 0.14 | 0.07 | |
Capex per Share |
(0.01) | (0.02) | (0.01) | (0.01) | |
Free Cash Flow per Share |
0.01 | 0.09 | 0.13 | 0.06 | |
Cash per Share |
1.24 | 1.52 | 1.13 | 1.11 | |
Shareholders Equity per Share |
5.27 | 5.18 | 5.08 | 4.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.27 | 5.18 | 5.08 | 4.99 | |
Free Cash Flow |
1.28 | 20.39 | 29.72 | 12.92 | |
Working Capital |
(35.74) | (21.70) | 95.47 | 104.20 | |
Capital Expenditures |
(1.87) | (3.99) | (1.24) | (1.72) | |
Net Current Asset Value |
(1,327.12) | (1,250.96) | (1,212.32) | (1,217.90) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.03 | 0.01 | 0.01 | |
Net Profit Margin |
10.43% | 12.03% | 11.41% | 9.71% | |
Price to Operating Income |
23.12 | 23.19 | 68.01 | 147.70 | |
| Other line items | |||||
Average Payables |
8,283.47 | 8,270.11 | 8,099.19 | 7,958.52 | |
Average Assets |
10,809.18 | 10,747.14 | 10,771.17 | 10,751.31 | |
Average Common Equity |
1,137.03 | 1,120.55 | 1,110.06 | 1,083.72 |
Columns are period end dates